Over the past weeks, the most dreaded words in regulatory law – “jurisdictional grey area” (dun dun dun) – have made Canadian headlines.
This phrase has been targeted at a recent chemo scandal in which five Canadian hospitals administered weaker-than-prescribed drugs to patients. The drugs at issue had been mixed by a drug compounding company in Mississauga, Ontario called Marchese Hospital Solutions.
continue reading here